Therapeutic management in patients with exocrine pancreatic insufficiency (EPI): First experience with the 13C-mixed triglyceride breath test (Pancreo-kit®)

Aim: assessing the 13C-mixed triglyceride breath test (Pancreo-kit®, 13C-TRG) influence in the management of EPI patients. Ten patients had received pancreatic or gastric surgery; 5 had alcohol abuse history; 14 patients had previous EPI (by fecal-elastase or Van de Kamer), being under ERT.

Saved in:
Bibliographic Details
Published in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2017-09, Vol.17 (5), p.S6-S7
Main Authors: del Pozo García, A.J., Martínez Montiel, P., Olivares, S., Sáenz López, S., Valdés, T., Garfia, C., Calatayud, M., Abad, M.I., Castellano Tortajada, G.
Format: Article
Language:English
Subjects:
Breath tests
Enzymes
Pancreas
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim: assessing the 13C-mixed triglyceride breath test (Pancreo-kit®, 13C-TRG) influence in the management of EPI patients. Ten patients had received pancreatic or gastric surgery; 5 had alcohol abuse history; 14 patients had previous EPI (by fecal-elastase or Van de Kamer), being under ERT.
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2017.08.031